Raymond F. Burk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Raymond F. Burk has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Kristina E. Hill
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
18 shared publicationsAmy K. Motley
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
15 shared publicationsKristina E Hill
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine
7 shared publicationsLori M. Austin
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, and
7 shared publicationsVirginia P. Winfrey
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
7 shared publications- Kristina E. Hill
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0252;
5 shared publications
Latest Publications
- 1 November 2015
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 102 (5) , 1126-1133
Selenium deficiency occurs in some patients with moderate-to-severe cirrhosis and can be corrected by administration of selenate but not selenomethionine: a randomized controlled trial
Background: Selenomethionine, which is the principal dietary form of selenium, is metabolized by the liver to selenide, which is the form of the eleme
- 1 November 2015
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 102 (5) , 1126-1133
Selenium deficiency occurs in some patients with moderate-to-severe cirrhosis and can be corrected by administration of selenate but not selenomethionine: a randomized controlled trial
Background: Selenomethionine, which is the principal dietary form of selenium, is metabolized by the liver to selenide, which is the form of the eleme
- Top Cited Papers
- 17 July 2015
- Published by Annual Reviews in Annual Review of Nutrition
- Vol. 35 (1) , 109-134
Regulation of Selenium Metabolism and Transport
Selenium is regulated in the body to maintain vital selenoproteins and to avoid toxicity. When selenium is limiting, cells utilize it to synthesize the selenoproteins most important to them, creating a selenoprotein hierarchy in the cell. The liver is the central organ for selenium regulation and produces excretory selenium forms to regulate whole-body selenium. It responds to selenium deficiency by curtailing excretion and secreting selenoprotein P (Sepp1) into the plasma at the expense of its intracellular selenoproteins. Plasma Sepp1 is distributed to tissues in relation to their expression of the Sepp1 receptor apolipoprotein E receptor-2, creating a tissue selenium hierarchy. N-terminal Sepp1 forms are taken up in the renal proximal tubule by another receptor, megalin. Thus, the regulated whole-body pool of selenium is shifted to needy cells and then to vital selenoproteins in them to supply selenium where it is needed, creating a whole-body selenoprotein hierarchy.
- 17 July 2015
- Published by Annual Reviews in Annual Review of Nutrition
- Vol. 35 (1) , 109-134
Top Cited PapersRegulation of Selenium Metabolism and Transport
Selenium is regulated in the body to maintain vital selenoproteins and to avoid toxicity. When selenium is limiting, cells utilize it to synthesize the selenoproteins most important to them, creating a selenoprotein hierarchy in the cell. The liver is the central organ for selenium regulation and produces excretory selenium forms to regulate whole-body selenium. It responds to selenium deficiency by curtailing excretion and secreting selenoprotein P (Sepp1) into the plasma at the expense of its intracellular selenoproteins. Plasma Sepp1 is distributed to tissues in relation to their expression of the Sepp1 receptor apolipoprotein E receptor-2, creating a tissue selenium hierarchy. N-terminal Sepp1 forms are taken up in the renal proximal tubule by another receptor, megalin. Thus, the regulated whole-body pool of selenium is shifted to needy cells and then to vital selenoproteins in them to supply selenium where it is needed, creating a whole-body selenoprotein hierarchy.
- Open Access
- 23 April 2014
- Published by Wiley in The FASEB Journal
- Vol. 28 (8) , 3579-3588
Selenoprotein P and apolipoprotein E receptor‐2 interact at the blood‐brain barrier and also within the brain to maintain an essential selenium pool that protects against neurodegeneration
Selenoprotein P (Sepp1) and its receptor, apolipoprotein E receptor 2 (apoER2), account for brain retaining selenium better than other tissues. The primary sources of Sepp1 in plasma and brain are hepatocytes and astrocytes, respectively. ApoER2 is expressed in varying amounts by tissues; within the brain it is expressed primarily by neurons. Knockout of Sepp1 or apoER2 lowers brain selenium from ~120 to ~50 ng/g and leads to severe neurodegeneration and death in mild selenium deficiency. Interactions of Sepp1 and apoER2 that protect against this injury have not been characterized. We studied Sepp1, apoER2, and brain selenium in knockout mice. Immunocytochemistry showed that apoER2 mediates Sepp1 uptake at the blood‐brain barrier. When Sepp1 –/– or apoER2 –/– mice developed severe neurodegeneration caused by mild selenium deficiency, brain selenium was ~35 ng/g. In extreme selenium deficiency, however, brain selenium of ~12 ng/g was tolerated when both Sepp1 and apoER2 were intact in the brain. These findings indicate that tandem Sepp1‐apoER2 interactions supply selenium for maintenance of brain neurons. One interaction is at the blood‐brain barrier, and the other is within the brain. We postulate that Sepp1 inside the blood‐brain barrier is taken up by neurons via apoER2, concentrating brain selenium in them.—Burk, R. F., Hill, K. E., Motley, A. K., Winfrey, V. P., Kurokawa, S., Mitchell, S. L., Zhang, W. Selenoprotein P and apolipoprotein E receptor‐2 interact at the blood‐brain barrier and also within the brain to maintain an essential selenium pool that protects against neurodegeneration. FASEB J. 28, 3579–3588 (2014). www.fasebj.org
- 23 April 2014
- Published by Wiley in The FASEB Journal
- Vol. 28 (8) , 3579-3588
Open AccessSelenoprotein P and apolipoprotein E receptor‐2 interact at the blood‐brain barrier and also within the brain to maintain an essential selenium pool that protects against neurodegeneration
Selenoprotein P (Sepp1) and its receptor, apolipoprotein E receptor 2 (apoER2), account for brain retaining selenium better than other tissues. The primary sources of Sepp1 in plasma and brain are hepatocytes and astrocytes, respectively. ApoER2 is expressed in varying amounts by tissues; within the brain it is expressed primarily by neurons. Knockout of Sepp1 or apoER2 lowers brain selenium from ~120 to ~50 ng/g and leads to severe neurodegeneration and death in mild selenium deficiency. Interactions of Sepp1 and apoER2 that protect against this injury have not been characterized. We studied Sepp1, apoER2, and brain selenium in knockout mice. Immunocytochemistry showed that apoER2 mediates Sepp1 uptake at the blood‐brain barrier. When Sepp1 –/– or apoER2 –/– mice developed severe neurodegeneration caused by mild selenium deficiency, brain selenium was ~35 ng/g. In extreme selenium deficiency, however, brain selenium of ~12 ng/g was tolerated when both Sepp1 and apoER2 were intact in the brain. These findings indicate that tandem Sepp1‐apoER2 interactions supply selenium for maintenance of brain neurons. One interaction is at the blood‐brain barrier, and the other is within the brain. We postulate that Sepp1 inside the blood‐brain barrier is taken up by neurons via apoER2, concentrating brain selenium in them.—Burk, R. F., Hill, K. E., Motley, A. K., Winfrey, V. P., Kurokawa, S., Mitchell, S. L., Zhang, W. Selenoprotein P and apolipoprotein E receptor‐2 interact at the blood‐brain barrier and also within the brain to maintain an essential selenium pool that protects against neurodegeneration. FASEB J. 28, 3579–3588 (2014). www.fasebj.org
- 1 April 2014
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 69, 67-76
Sepp1UF forms are N-terminal selenoprotein P truncations that have peroxidase activity when coupled with thioredoxin reductase-1
- 1 April 2014
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 69, 67-76
Sepp1UF forms are N-terminal selenoprotein P truncations that have peroxidase activity when coupled with thioredoxin reductase-1
- Open Access
- 1 August 2013
- Published by Elsevier in The Journal of Nutrition
- Vol. 143 (8) , 1203-1204
Orville A. Levander, PhD: 1940–2011
The nutrition community will remember Orville Arvid Levander for his pioneering research on human selenium nutrition and his public health-related research (Sup
- 1 August 2013
- Published by Elsevier in The Journal of Nutrition
- Vol. 143 (8) , 1203-1204
Open AccessOrville A. Levander, PhD: 1940–2011
The nutrition community will remember Orville Arvid Levander for his pioneering research on human selenium nutrition and his public health-related research (Sup
- Open Access
- 7 May 2013
- Published by Wiley in The FASEB Journal
- Vol. 27 (8) , 3249-3256
Maternal‐fetal transfer of selenium in the mouse
Selenoprotein P (Sepp1) is taken up by receptor‐mediated endocytosis for its selenium. The other extracellular selenoprotein, glutathione peroxidase‐3 (Gpx3), has not been shown to transport selenium. Mice with genetic alterations of Sepp1, the Sepp1 receptors apolipoprotein E receptor‐2 (apoER2) and megalin, and Gpx3 were used to investigate maternalfetal selenium transfer. Immunocytochemistry (ICC) showed receptor‐independent uptake of Sepp1 and Gpx3 in the same vesicles of d‐13 visceral yolk sac cells, suggesting uptake by pinocytosis. ICC also showed apoER2‐mediated uptake of maternal Sepp1 in the d‐18 placenta. Thus, two selenoprotein‐dependent maternalfetal selenium transfer mechanisms were identified. Selenium was quantified in d‐18 fetuses with the mechanisms disrupted. Maternal Sepp1 deletion, which lowers maternal whole‐body selenium, decreased fetal selenium under selenium‐adequate conditions but deletion of fetal apoER2 did not. Fetal apoER2 deletion did decrease fetal selenium, by 51%, under selenium‐deficient conditions, verifying function of the placental Sepp1‐apoER2 mechanism. Maternal Gpx3 deletion decreased fetal selenium, by 13%, but only under selenium‐deficient conditions. These findings indicate that the selenoprotein uptake mechanisms ensure selenium transfer to the fetus under selenium‐deficient conditions. The failure of their disruptions ( apoER2 deletion, Gpx3 deletion) to affect fetal selenium under selenium‐adequate conditions indicates the existence of an additional maternal‐fetal selenium transfer mechanism.—Burk, R. F., Olson, G. E., Hill, K. E., Winfrey, V. P., Motley, A. K., and Kurokawa, S., Maternal‐fetal transfer of selenium in the mouse. FASEB J. 27, 3249–3256 (2013). www.fasebj.org
- 7 May 2013
- Published by Wiley in The FASEB Journal
- Vol. 27 (8) , 3249-3256
Open AccessMaternal‐fetal transfer of selenium in the mouse
Selenoprotein P (Sepp1) is taken up by receptor‐mediated endocytosis for its selenium. The other extracellular selenoprotein, glutathione peroxidase‐3 (Gpx3), has not been shown to transport selenium. Mice with genetic alterations of Sepp1, the Sepp1 receptors apolipoprotein E receptor‐2 (apoER2) and megalin, and Gpx3 were used to investigate maternalfetal selenium transfer. Immunocytochemistry (ICC) showed receptor‐independent uptake of Sepp1 and Gpx3 in the same vesicles of d‐13 visceral yolk sac cells, suggesting uptake by pinocytosis. ICC also showed apoER2‐mediated uptake of maternal Sepp1 in the d‐18 placenta. Thus, two selenoprotein‐dependent maternalfetal selenium transfer mechanisms were identified. Selenium was quantified in d‐18 fetuses with the mechanisms disrupted. Maternal Sepp1 deletion, which lowers maternal whole‐body selenium, decreased fetal selenium under selenium‐adequate conditions but deletion of fetal apoER2 did not. Fetal apoER2 deletion did decrease fetal selenium, by 51%, under selenium‐deficient conditions, verifying function of the placental Sepp1‐apoER2 mechanism. Maternal Gpx3 deletion decreased fetal selenium, by 13%, but only under selenium‐deficient conditions. These findings indicate that the selenoprotein uptake mechanisms ensure selenium transfer to the fetus under selenium‐deficient conditions. The failure of their disruptions ( apoER2 deletion, Gpx3 deletion) to affect fetal selenium under selenium‐adequate conditions indicates the existence of an additional maternal‐fetal selenium transfer mechanism.—Burk, R. F., Olson, G. E., Hill, K. E., Winfrey, V. P., Motley, A. K., and Kurokawa, S., Maternal‐fetal transfer of selenium in the mouse. FASEB J. 27, 3249–3256 (2013). www.fasebj.org
- Open Access
- 1 November 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (48) , 40414-40424
Production of Selenoprotein P (Sepp1) by Hepatocytes Is Central to Selenium Homeostasis
- 1 November 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (48) , 40414-40424
Open AccessProduction of Selenoprotein P (Sepp1) by Hepatocytes Is Central to Selenium Homeostasis
- Open Access
- 1 August 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (34) , 28717-28726
Long Isoform Mouse Selenoprotein P (Sepp1) Supplies Rat Myoblast L8 Cells with Selenium via Endocytosis Mediated by Heparin Binding Properties and Apolipoprotein E Receptor-2 (ApoER2)
- 1 August 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (34) , 28717-28726
Open AccessLong Isoform Mouse Selenoprotein P (Sepp1) Supplies Rat Myoblast L8 Cells with Selenium via Endocytosis Mediated by Heparin Binding Properties and Apolipoprotein E Receptor-2 (ApoER2)
- 6 May 2012
- Published by Springer Nature in Biological Trace Element Research
- Vol. 149 (3) , 377-381
Fecal Selenium Excretion Is Regulated by Dietary Selenium Intake
Whole-body selenium is regulated by excretion of the element. Reports of studies carried out using isotopic tracers have led to the conclusion that urinary selenium excretion is regulated by selenium intake but that fecal excretion is not. Because of the limitations of tracer studies, we measured urinary and fecal selenium excretion by mice with selenium intakes in the form of sodium selenite ranging from deficient to almost toxic. Tissue and whole-body selenium concentrations increased sharply between deficient and adequate selenium intakes, reflecting tissue accumulation of selenium in the form of selenoproteins. Once the requirement for selenium had been satisfied, a 31-fold further increase in intake resulted in less than doubling of tissue and whole-body selenium, demonstrating the effectiveness of selenium excretion by the mouse. Urinary selenium excretion increased with increases in dietary selenium intake. Fecal selenium excretion, which was 20 to 30 % of the selenium excreted in the physiological range, responded to moderately high selenium intake but did not increase further when selenium intake was increased to even higher levels. Thus, fecal selenium excretion contributes to regulation of whole-body selenium at physiological selenium intakes. The pattern of its response to the full spectrum of selenium intakes was different from the urinary excretion response, suggesting that the mechanisms of fecal and urinary routes of excretion are different.
- 6 May 2012
- Published by Springer Nature in Biological Trace Element Research
- Vol. 149 (3) , 377-381
Fecal Selenium Excretion Is Regulated by Dietary Selenium Intake
Whole-body selenium is regulated by excretion of the element. Reports of studies carried out using isotopic tracers have led to the conclusion that urinary selenium excretion is regulated by selenium intake but that fecal excretion is not. Because of the limitations of tracer studies, we measured urinary and fecal selenium excretion by mice with selenium intakes in the form of sodium selenite ranging from deficient to almost toxic. Tissue and whole-body selenium concentrations increased sharply between deficient and adequate selenium intakes, reflecting tissue accumulation of selenium in the form of selenoproteins. Once the requirement for selenium had been satisfied, a 31-fold further increase in intake resulted in less than doubling of tissue and whole-body selenium, demonstrating the effectiveness of selenium excretion by the mouse. Urinary selenium excretion increased with increases in dietary selenium intake. Fecal selenium excretion, which was 20 to 30 % of the selenium excreted in the physiological range, responded to moderately high selenium intake but did not increase further when selenium intake was increased to even higher levels. Thus, fecal selenium excretion contributes to regulation of whole-body selenium at physiological selenium intakes. The pattern of its response to the full spectrum of selenium intakes was different from the urinary excretion response, suggesting that the mechanisms of fecal and urinary routes of excretion are different.